Search Results - "Kristian, Alexandr"

Refine Results
  1. 1

    B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation by Liu, Hao, Tekle, Christina, Chen, Yih-Wen, Kristian, Alexandr, Zhao, Yuhua, Zhou, Ming, Liu, Zixing, Ding, Yan, Wang, Bin, Mælandsmo, Gunhild Mari, Nesland, Jahn Marthin, Fodstad, Oystein, Tan, Ming

    Published in Molecular cancer therapeutics (01-06-2011)
    “…In many types of cancer, the expression of the immunoregulatory protein B7-H3 has been associated with poor prognosis. Previously, we observed a link between…”
    Get full text
    Journal Article
  2. 2

    Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist by Pitman, Kathinka E, Bakke, Kine M, Kristian, Alexandr, Malinen, Eirik

    Published in Cancer imaging (19-12-2019)
    “…Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) may be used to depict tumour vascular structure and for therapy response assessment in various…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations by LINDHOLM, Evita M, KROHN, Marit, IADEVAIA, Sergio, KRISTIAN, Alexandr, MILLS, Gordon B, MNLANDSMO, Gunhild M, ENGEBRAATEN, Olav

    Published in Clinical cancer research (15-01-2014)
    “…Neoangiogenesis is an important feature in tumor growth and progression, and combining chemotherapy and antiangiogenic drugs have shown clinical efficacy…”
    Get full text
    Journal Article
  6. 6

    Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma by Prasmickaite, Lina, Engesaeter, Birgit Ø, Skrbo, Nirma, Hellenes, Tina, Kristian, Alexandr, Oliver, Nina K, Suo, Zhenhe, Maelandsmo, Gunhild M

    Published in PloS one (20-05-2010)
    “…Malignant melanoma is an exceptionally aggressive, drug-resistant and heterogeneous cancer. Recently it has been shown that melanoma cells with high clonogenic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer by Moestue, Siver A, Dam, Cornelia G, Gorad, Saurabh S, Kristian, Alexandr, Bofin, Anna, Mælandsmo, Gunhild M, Engebråten, Olav, Gribbestad, Ingrid S, Bjørkøy, Geir

    Published in Breast cancer research : BCR (28-02-2013)
    “…The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in cancer cells through numerous mutations and epigenetic changes. The recent…”
    Get full text
    Journal Article
  9. 9

    Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts by Bruheim, Skjalg, Kristian, Alexandr, Uenaka, Toshimitsu, Suo, Zhenhe, Tsuruoka, Akihiko, Nesland, Jahn M., Fodstad, Øystein

    Published in International journal of cancer (01-08-2011)
    “…E7080 is an inhibitor of multiple tyrosine kinases, several of which have pro‐angiogenic properties, including receptors for VEGF, FGF, SCF and PDGF. We…”
    Get full text
    Journal Article
  10. 10

    Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft by Skrbo, Nirma, Hjortland, Geir-Olav, Kristian, Alexandr, Holm, Ruth, Nord, Silje, Prasmickaite, Lina, Engebraaten, Olav, Mælandsmo, Gunhild M, Sørlie, Therese, Andersen, Kristin

    Published in PloS one (24-11-2014)
    “…Intratumor heterogeneity caused by genetic, phenotypic or functional differences between cancer cell subpopulations is a considerable clinical challenge…”
    Get full text
    Journal Article
  11. 11

    Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma by Saelen, Marie Grøn, Ree, Anne Hansen, Kristian, Alexandr, Fleten, Karianne Giller, Furre, Torbjørn, Hektoen, Helga Helseth, Flatmark, Kjersti

    Published in Radiation oncology (London, England) (27-09-2012)
    “…The histone deacetylase inhibitor vorinostat is a candidate radiosensitizer in locally advanced rectal cancer (LARC). Radiosensitivity is critically influenced…”
    Get full text
    Journal Article
  12. 12

    Exploring the peritoneal surface malignancy phenotype—a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models by Flatmark, Kjersti, MD, PhD, Davidson, Ben, MD, PhD, Kristian, Alexandr, MSc, Stavnes, Helene Tuft, MSc, Førsund, Mette, MSc, Reed, Wenche, MD, PhD

    Published in Human pathology (01-08-2010)
    “…Summary Peritoneal surface malignancies are characterized by the propensity for tumor growth on peritoneal surfaces without development of extraperitoneal…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study by Sørensen, Olaf, Andersen, Anders, Olsen, Harald, Alexandr, Kristian, Ekstrøm, Per Olaf, Giercksky, Karl-Erik, Flatmark, Kjersti

    Published in BMC cancer (01-09-2010)
    “…Mitomycin C is a chemotherapeutic agent used in the treatment of peritoneal surface malignancies, administered as hyperthermic intraperitoneal chemotherapy…”
    Get full text
    Journal Article
  15. 15

    Dynamic 18F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts by Alexandr Kristian, Line B. Nilsen, Kathrine Roe, Mona-Elisabeth Revheim, Olav Engebråten, Gunhild M. Mælandsmo, Ruth Holm, Eirik Malinen, Therese Seierstad

    Published in Nuclear medicine and molecular imaging (01-09-2013)
    “…Purpose To compare dynamic 2-deoxy-2-[18F]fluoro-Dglucose positron emission tomography (18F-FDG PET) parameters in two selected human breast cancer xenografts…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts by Kristian, Alexandr, Revheim, Mona Elisabeth, Qu, Hong, Mælandsmo, Gunhild M, Engebråten, Olav, Seierstad, Therese, Malinen, Eirik

    Published in Acta oncologica (01-10-2013)
    “…Dynamic (18)F-FDG PET allows the study of glucose distribution in tissues as a function of time and space. Using pharmacokinetics, the temporal uptake pattern…”
    Get more information
    Journal Article
  19. 19

    Variability of dynamic 18F-FDG-PET data in breast cancer xenografts by Pitman, Kathinka E, Rusten, Espen, Kristian, Alexandr, Malinen, Eirik

    Published in Acta oncologica (21-10-2015)
    “…A murine breast cancer xenograft model was employed to evaluate inter- and intra-variability of various parameters derived from dynamic positron emission…”
    Get more information
    Journal Article
  20. 20

    Abstract 2053: Dynamic 18F-FDG PET parameters variation in patient-derived breast cancer xenograft and correlation with outcome following treatment with cytotoxic agents by Kristian, Alexandr, Revheim, Mona-Elizabeth, Qu, Hong, Mælandsmo, Gunhild, Engebraaten, Olav, Malinen, Eirik

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Using pharmacokinetic modeling for dynamic 18FDG PET (D-PET) the temporal and spatial uptake pattern of 18FDG may be separated into components…”
    Get full text
    Journal Article